COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023
Silk BJ, Scobie HM, Duck WM, et al. MMWR Morb Mortal Wkly Rep 2023;72:523–528.
http://dx.doi.org/10.15585/mmwr.mm7219e1.
Summary
What is already known about this topic?
Authorizations to collect certain public health data expire at the end of the U.S. public health emergency declaration on May 11, 2023.
What is added by this report?
Changes to the national COVID-19 monitoring strategy and COVID Data Tracker capitalize on marked improvements in multiple surveillance systems. Weekly COVID-19 hospital admission levels and the percentage of all COVID-19–associated deaths will be primary surveillance indicators. Emergency department visits and percentage of positive SARS-CoV-2 laboratory test results will help detect early changes in trends. Genomic surveillance will continue to help identify and monitor SARS-CoV-2 variants.
What are the implications for public health practice?
COVID-19 is an ongoing public health problem that will be monitored with sustainable data sources to guide prevention efforts.”